Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling

This article was originally published in The Gray Sheet

Executive Summary

In a watershed decision, a federal appeals court declares that manufacturers cannot be prosecuted under the Federal Food, Drug & Cosmetic Act’s misbranding provisions solely for speech promoting off-label use. Industry attorneys predict the decision, if it stands, will change the government’s approach to pursuing such cases.


Related Content

News In Brief
DOJ Unlikely To Take Off-Label Promotion Case To Supreme Court, Attorneys Say
Off-Label Questions, Online: FDA Explains How To Handle Them

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts